Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 Assay.
Saved in:
| Title: | Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 Assay. |
|---|---|
| Authors: | Adams HP; Signature Diagnostics GmbH, Potsdam, Germany., Hiemenz MC; Foundation Medicine, Inc., Cambridge, Massachusetts., Hertel K; Helios MVZ Pathologie Erfurt GmbH, Erfurt, Germany., Fuhlbrück F; Signature Diagnostics GmbH, Potsdam, Germany., Thomas M; F. Hoffmann-La Roche AG, Basel, Switzerland., Oughton J; Foundation Medicine, Inc., Cambridge, Massachusetts., Sorensen H; Roche Diagnostics Solutions, Inc., Santa Clara, California., Schlecht U; Signature Diagnostics GmbH, Potsdam, Germany., Allen JM; Foundation Medicine, Inc., Cambridge, Massachusetts., Cantone M; Lab Operations, Foundation Medicine GmbH, Penzberg, Germany., Osswald S; Lab Operations, Foundation Medicine GmbH, Penzberg, Germany., Gonzalez D; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom., Pikarsky E; The Lautenberg Center for Immunology, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel., De Vos M; Roche Diagnostics Solutions, Rotkreuz, Switzerland., Schuuring E; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Wieland T; Lab Operations, Foundation Medicine GmbH, Penzberg, Germany. Electronic address: twieland@foundationmedicine.com. |
| Source: | The Journal of molecular diagnostics : JMD [J Mol Diagn] 2024 Nov; Vol. 26 (11), pp. 1018-1033. Date of Electronic Publication: 2024 Sep 11. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39270817 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 Assay. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Adams+HP%22">Adams HP</searchLink>; Signature Diagnostics GmbH, Potsdam, Germany.<br /><searchLink fieldCode="AU" term="%22Hiemenz+MC%22">Hiemenz MC</searchLink>; Foundation Medicine, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hertel+K%22">Hertel K</searchLink>; Helios MVZ Pathologie Erfurt GmbH, Erfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Fuhlbrück+F%22">Fuhlbrück F</searchLink>; Signature Diagnostics GmbH, Potsdam, Germany.<br /><searchLink fieldCode="AU" term="%22Thomas+M%22">Thomas M</searchLink>; F. Hoffmann-La Roche AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Oughton+J%22">Oughton J</searchLink>; Foundation Medicine, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sorensen+H%22">Sorensen H</searchLink>; Roche Diagnostics Solutions, Inc., Santa Clara, California.<br /><searchLink fieldCode="AU" term="%22Schlecht+U%22">Schlecht U</searchLink>; Signature Diagnostics GmbH, Potsdam, Germany.<br /><searchLink fieldCode="AU" term="%22Allen+JM%22">Allen JM</searchLink>; Foundation Medicine, Inc., Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Cantone+M%22">Cantone M</searchLink>; Lab Operations, Foundation Medicine GmbH, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Osswald+S%22">Osswald S</searchLink>; Lab Operations, Foundation Medicine GmbH, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gonzalez+D%22">Gonzalez D</searchLink>; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pikarsky+E%22">Pikarsky E</searchLink>; The Lautenberg Center for Immunology, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22De+Vos+M%22">De Vos M</searchLink>; Roche Diagnostics Solutions, Rotkreuz, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schuuring+E%22">Schuuring E</searchLink>; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Wieland+T%22">Wieland T</searchLink>; Lab Operations, Foundation Medicine GmbH, Penzberg, Germany. Electronic address: twieland@foundationmedicine.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100893612%22">The Journal of molecular diagnostics : JMD</searchLink> [J Mol Diagn] 2024 Nov; Vol. 26 (11), pp. 1018-1033. <i>Date of Electronic Publication: </i>2024 Sep 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893612 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1943-7811 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215251578%22">15251578 </searchLink><i>NLM ISO Abbreviation: </i>J Mol Diagn <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39270817 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jmoldx.2024.08.001 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1018 Titles: – TitleFull: Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 Assay. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Adams HP – PersonEntity: Name: NameFull: Hiemenz MC – PersonEntity: Name: NameFull: Hertel K – PersonEntity: Name: NameFull: Fuhlbrück F – PersonEntity: Name: NameFull: Thomas M – PersonEntity: Name: NameFull: Oughton J – PersonEntity: Name: NameFull: Sorensen H – PersonEntity: Name: NameFull: Schlecht U – PersonEntity: Name: NameFull: Allen JM – PersonEntity: Name: NameFull: Cantone M – PersonEntity: Name: NameFull: Osswald S – PersonEntity: Name: NameFull: Gonzalez D – PersonEntity: Name: NameFull: Pikarsky E – PersonEntity: Name: NameFull: De Vos M – PersonEntity: Name: NameFull: Schuuring E – PersonEntity: Name: NameFull: Wieland T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2024 Nov Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1943-7811 Numbering: – Type: volume Value: 26 – Type: issue Value: 11 Titles: – TitleFull: The Journal of molecular diagnostics : JMD Type: main |
| ResultId | 1 |
